- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Small cell lung cancer is a type of highly malignant cancer that appears in the lungs. In opposition to non-small cell cancer, this type has a shorter doubling time, higher growth rate and earlier development of metastases. This type of lung cancer sums up to around 15% of all lung cancers.
Showing all 2 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
03/2022 |
262,80 € |
||
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
05/2023 |
262,80 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin